search
Back to results

Laser Therapy for Treating Hypertrophic Burn Scars in Children (LaserTherapy)

Primary Purpose

Burn Scars

Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Pulse-Dye Laser
Sham
Sponsored by
Massachusetts General Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Burn Scars focused on measuring Pediatric, Burns, Scars, Pulse Dye laser

Eligibility Criteria

9 Years - 21 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • subjects 9 years and older to 21 years of age or younger with a second degree burn with erythema and the potential for hypertrophic scarring to the thigh and or trunk.
  • subject is clinically stable within 3 months of the burn injury.
  • burn size of at least 15cm2 and able to be divided into equivalent halves (divided along line of tension). Equivalent orientation distance from mobil joint with regard to history,physical findings, proximity to tension producing forces and orientation.
  • subjects in acute phase of burn injury generally less than one year from the time of the burn injury at 2-3 months post burn when deemed appropriate for pressure therapy, and have been evaluated as an appropriate candidate by a surgeon involved in this study for inclusion.
  • subjects can be included up to one year post burn if referred from another treatment facility.
  • no skin conditions that could potentially have an adverse effect on wound healing
  • all race/ethnic groups
  • children/guardians or significant others ability to speak English or Spanish and respond to study questionnaires.

Exclusion Criteria:

  • subjects less than 9 years old as this age group is more fragile.
  • subjects with no second degree burn to thigh and or trunk
  • subjects with chemical burns
  • subjects at low risk for hypertrophic scaring (wounds that demonstrate fading erythema at 9-12 weeks and wounds that are healed at less than 3 weeks are at low risk for hypertrophic scaring). Vancouver scar scale pigmentation rating of 0 or 1, vascularity rating of 0 or 1.
  • TBSA greater than 50% as massive burns will confound results.
  • potential life threatening injuries which would confound the effects of laser treatment and complicate sequential administration of therapy (e.g. shock,sepsis,inhalation therapies, brain injury).
  • subjects with other inclusion criteria not met and evaluation by surgeon negative for inclusion in study.
  • children/guardians or significant others inability to speak English or Spanish and respond to questionnaires.
  • SUBJECTS WITH DOCUMENTED HYPERSENSITIVITY/ALLERGY TO AQUAPHOR,LIDOCAINE OR ANY OF THEIR COMPONENTS.

Sites / Locations

  • Shriners Hospitals for Children

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Sham Comparator

Arm Label

Pulse Dye Laser, burn scars

No treatment to half of scar

Arm Description

A scar will be located on the study subject's torso or thigh and divided in half. Some subjects will receive laser to both sides of their scar, while others will not receive any intervention to one side and laser to the other side. Each side will be evaluated during outpatient visits. 12 months after treatment is completed, 2 burn experts will rate each side of the scar without knowing its treatment.

A scar on the child's torso or thigh will be divided in half. One side will receive laser treatment and the other half will receive laser or sham treatment.

Outcomes

Primary Outcome Measures

Matching Assessment of Scars and Photographs
This scar assessment tool uses a set of reference photographs, a numeric scale, and location technique to measure change over time of a burn scar. This tool will assist us in determining the comparative merits of laser treatments. It is portable and inexpensive.

Secondary Outcome Measures

Burn Outcomes Questionnaire
The ABA/SHC Burn Outcomes Questionnaires are burn and age specific. Questions include those about itch, appearance and function; all elements of daily life that may be compromised by hypertrophic scars.

Full Information

First Posted
July 27, 2012
Last Updated
July 30, 2012
Sponsor
Massachusetts General Hospital
Collaborators
Shriners Hospitals for Children
search

1. Study Identification

Unique Protocol Identification Number
NCT01653691
Brief Title
Laser Therapy for Treating Hypertrophic Burn Scars in Children
Acronym
LaserTherapy
Official Title
Tunable-Dye Laser Therapy to Ameliorate Hypertrophic Scarring in Burned Children
Study Type
Interventional

2. Study Status

Record Verification Date
July 2012
Overall Recruitment Status
Unknown status
Study Start Date
May 2012 (undefined)
Primary Completion Date
March 2014 (Anticipated)
Study Completion Date
January 2015 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Massachusetts General Hospital
Collaborators
Shriners Hospitals for Children

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Pulse-dye laser therapy has been used to treat the redness, tightness and discomfort of hypertrophic scars resulting from burn injuries. To date the effectiveness of laser therapy on children's burned scars has not been measured.
Detailed Description
In this study we hope to answer an important question in pediatric burn care: what are the techniques whereby tunable-dye laser neo-vessel ablation is optimally employed to ameliorate hypertrophic scars resulting from burn injuries in children? Hypertrophic scarring is considered an adverse wound healing event that results in abnormal scar formation. This scarring process is associated with pruritis and discomfort and can interfere with function and aesthetics. Topical creams, massage, stretching and pressure are used as standard treatments of burn scar formation. With the child serving as their own control, we want to objectively measure the impact of PDL on burn scars in children. Variables of timing of application, duration and number of sessions will all be collected.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Burn Scars
Keywords
Pediatric, Burns, Scars, Pulse Dye laser

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
80 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Pulse Dye Laser, burn scars
Arm Type
Active Comparator
Arm Description
A scar will be located on the study subject's torso or thigh and divided in half. Some subjects will receive laser to both sides of their scar, while others will not receive any intervention to one side and laser to the other side. Each side will be evaluated during outpatient visits. 12 months after treatment is completed, 2 burn experts will rate each side of the scar without knowing its treatment.
Arm Title
No treatment to half of scar
Arm Type
Sham Comparator
Arm Description
A scar on the child's torso or thigh will be divided in half. One side will receive laser treatment and the other half will receive laser or sham treatment.
Intervention Type
Procedure
Intervention Name(s)
Pulse-Dye Laser
Other Intervention Name(s)
Candela V-Beam tunable dye laser.
Intervention Description
Laser therapy will be applied to either one half or both halves of the subject's burn scar. Laser will be re-applied every 4-6 weeks for a total of 3 administrations.
Intervention Type
Procedure
Intervention Name(s)
Sham
Other Intervention Name(s)
No treatment
Intervention Description
No treatment to one side of subject's scar.
Primary Outcome Measure Information:
Title
Matching Assessment of Scars and Photographs
Description
This scar assessment tool uses a set of reference photographs, a numeric scale, and location technique to measure change over time of a burn scar. This tool will assist us in determining the comparative merits of laser treatments. It is portable and inexpensive.
Time Frame
12 months after the first laser procedure is completed
Secondary Outcome Measure Information:
Title
Burn Outcomes Questionnaire
Description
The ABA/SHC Burn Outcomes Questionnaires are burn and age specific. Questions include those about itch, appearance and function; all elements of daily life that may be compromised by hypertrophic scars.
Time Frame
Baseline completion after enrollment and again at 1st,2nd, 3rd, 4th,5th and 6th outpatient visits.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
9 Years
Maximum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: subjects 9 years and older to 21 years of age or younger with a second degree burn with erythema and the potential for hypertrophic scarring to the thigh and or trunk. subject is clinically stable within 3 months of the burn injury. burn size of at least 15cm2 and able to be divided into equivalent halves (divided along line of tension). Equivalent orientation distance from mobil joint with regard to history,physical findings, proximity to tension producing forces and orientation. subjects in acute phase of burn injury generally less than one year from the time of the burn injury at 2-3 months post burn when deemed appropriate for pressure therapy, and have been evaluated as an appropriate candidate by a surgeon involved in this study for inclusion. subjects can be included up to one year post burn if referred from another treatment facility. no skin conditions that could potentially have an adverse effect on wound healing all race/ethnic groups children/guardians or significant others ability to speak English or Spanish and respond to study questionnaires. Exclusion Criteria: subjects less than 9 years old as this age group is more fragile. subjects with no second degree burn to thigh and or trunk subjects with chemical burns subjects at low risk for hypertrophic scaring (wounds that demonstrate fading erythema at 9-12 weeks and wounds that are healed at less than 3 weeks are at low risk for hypertrophic scaring). Vancouver scar scale pigmentation rating of 0 or 1, vascularity rating of 0 or 1. TBSA greater than 50% as massive burns will confound results. potential life threatening injuries which would confound the effects of laser treatment and complicate sequential administration of therapy (e.g. shock,sepsis,inhalation therapies, brain injury). subjects with other inclusion criteria not met and evaluation by surgeon negative for inclusion in study. children/guardians or significant others inability to speak English or Spanish and respond to questionnaires. SUBJECTS WITH DOCUMENTED HYPERSENSITIVITY/ALLERGY TO AQUAPHOR,LIDOCAINE OR ANY OF THEIR COMPONENTS.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Martha Lydon, RN,BS
Phone
617-371-4808
Email
mlydon@shrinenet.org
First Name & Middle Initial & Last Name or Official Title & Degree
Michelle I Hinson, RN
Phone
617-371-4809
Email
mhinson@shrinenet.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Matthias Donelan, MD
Organizational Affiliation
Shriners Hospitals for Children-Boston MA USA
Official's Role
Principal Investigator
Facility Information:
Facility Name
Shriners Hospitals for Children
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45229-3095
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kevin Bailey, MD
Phone
513-872-6000
Email
kbailey@shrinenet.org
First Name & Middle Initial & Last Name & Degree
Richard Kagan, MD
Phone
513-872-6000
Email
rkagan@shrinenet.org
First Name & Middle Initial & Last Name & Degree
Kevin Bailey, MD

12. IPD Sharing Statement

Learn more about this trial

Laser Therapy for Treating Hypertrophic Burn Scars in Children

We'll reach out to this number within 24 hrs